PALISADE BIO INC
PALILatest QuantConomy context for PALI: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
PALISADE BIO INC
QuantConomy has a structured record for PALI. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- PALI
- Name
- PALISADE BIO INC
- Coverage
- 3 market/data records
- Sources
- alpaca fmp alphavantage sec nasdaq openfigi
Recent signals for PALI
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings earnings release | neutral | 40 | May 12, 12:00 AM | PALI filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-05-12. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| corporate event executive change | neutral | 90 | Jun 11, 09:25 PM | PALI filed 8-K: Director or Officer Changes, Articles/Bylaws Amendment, Shareholder Vote Results - 1 material event - [very strong neutral signal] |
| corporate event earnings | neutral | 75 | May 12, 08:21 PM | PALI filed 8-K: Earnings Release - 1 material event - [strong neutral signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| PALI | NASDAQ | alpaca | Palisade Bio, Inc. Common Stock |
| PALI | NASDAQ | fmp | Palisade Bio, Inc. |
| PALI | NASDAQ | alphavantage | Palisade Bio Inc |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Finley John David | CEO, CFO | exercise | 335,167 | — | — | 4 on EDGAR |
| Jul 6, 2026 | Jones Mitchell Lawrence | Chief Medical Officer | exercise | 131,167 | — | — | 4 on EDGAR |
| Jul 6, 2026 | Baltera Robert Jr. | Insider | purchase | 20,000 | $2.05 | $41,040 | 4 on EDGAR |
| Jul 1, 2026 | Baltera Robert Jr. | Insider | purchase | 20,000 | $1.98 | $39,600 | 4 on EDGAR |
| Jun 10, 2026 | Wei Binxian | Insider | grant | 592,300 | — | — | 4 on EDGAR |
| Jun 10, 2026 | Williams Donald Allen | Insider | grant | 1,498,900 | — | — | 4 on EDGAR |
| Jun 10, 2026 | Baltera Robert Jr. | Insider | grant | 336,904 | — | — | 4 on EDGAR |
| Jun 10, 2026 | Chuang Emil | Insider | grant | 592,300 | — | — | 4 on EDGAR |
| Feb 11, 2026 | Jones Mitchell Lawrence | Chief Medical Officer | exercise | 8,000 | — | — | 4 on EDGAR |
| Feb 11, 2026 | Finley John David | CEO, CFO | exercise | 13,333 | — | — | 4 on EDGAR |
| Feb 9, 2026 | Jones Mitchell Lawrence | Chief Medical Officer | grant | 787,000 | — | — | 4 on EDGAR |
| Feb 9, 2026 | Finley John David | CEO, CFO | grant | 2,011,000 | — | — | 4 on EDGAR |
| Jan 16, 2026 | Williams Donald Allen | Insider | purchase | 5,000 | $1.67 | $8,356 | 4 on EDGAR |
| Jan 9, 2026 | Williams Donald Allen | Insider | purchase | 5,000 | $1.88 | $9,400 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query PALI context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access